Jeffrey R. Jay’s Protalix BioTherapeutics PLX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2013
Q2
$1.96M Buy
+39,901
New +$1.96M 1.55% 17